You may recall that my father-in-law has acute myelogous leukemia (aml). As I mentioned before, the typical prognosis for an aml diagnosis is 6-9 months from date of diagnosis, and he was diagnosed in August of 2006.
Well, apparently MD Anderson, a cancer clinic in Houston, is in Phase II trials of a new drug for aml. My father-in-law is going down in the next couple of weeks to be interviewed to see if he qualifies.
I'm not getting my hopes up too high; he could either not qualify for the program or not respond to the drug. I had a good friend go through several trials (phases I, II and III) for non-Hodgkins lymphoma a few years ago with no apparent results. I miss him to this day.